The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

Glucagon-like peptide 1 receptor agonists have shown cardioprotective effects which have been suggested to be mediated through inhibition of oxidative stress. We investigated the effect of treatment with a glucagon-like peptide 1 receptor agonist (liraglutide) on oxidative stress measured as urinary...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivalingam, Suvanjaa, Larsen, Emil List, van Raalte, Daniel H., Muskiet, Marcel H. A., Smits, Mark M., Tonneijck, Lennart, Joles, Jaap A., von Scholten, Bernt Johan, Zobel, Emilie Hein, Persson, Frederik, Henriksen, Trine, Diaz, Lars Jorge, Hansen, Tine W., Poulsen, Henrik Enghusen, Rossing, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134438/
https://www.ncbi.nlm.nih.gov/pubmed/34012064
http://dx.doi.org/10.1038/s41598-021-90191-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134438/
https://www.ncbi.nlm.nih.gov/pubmed/34012064
http://dx.doi.org/10.1038/s41598-021-90191-w

Ejemplares similares